Veracyte Inc. (VCYT) Soars 9.08% on January 03

Veracyte Inc. (VCYT) Soars 9.08% on January 03

Veracyte Inc. (VCYT) had a good day on the market for Thursday January 03 as shares jumped 9.08% to close at $13.09. About 437,761 shares traded hands on 3,756 trades for the day, compared with an average daily volume of n/a shares out of a total float of 40.54 million. After opening the trading day at $12.05, shares of Veracyte Inc. stayed within a range of $13.46 to $12.05.

With today’s gains, Veracyte Inc. now has a market cap of $530.65 million. Shares of Veracyte Inc. have been trading within a range of $15.50 and $5.23 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.

Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against the diseases such as thyroid cancer, lung cancer etc. The firm’s product portfolio consists of products such as Afirma analysis, Percepta classifier and Envisia classifier. It also has products pipeline such as Enhanced afirma GEC and Expanded indications for the Percepta classifier. The company derives its revenues from the Sale of Afirma analysis product.

Veracyte Inc. is based out of South San Francisco, CA and has some 246 employees. Its CEO is Bonnie H. Anderson.

Scroll Up
error: Content is protected !!